Antonio Abbate, MD, PhD
Virginia Commonwealth University
12
12
11
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Benjamin Van Tassell, PharmD
Virginia Commonwealth University
Shared therapeutic areas:
Worked with same sponsors:
Benjamin W Van Tassell, PharmD
Virginia Commonwealth University
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Andrea Natale, MD
Texas Cardiac Arrhythmia Research Foundation
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Meral Boşnak Güçlü, Prof. Dr.
Gazi University
Shared therapeutic areas:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Worked with same sponsors:
Dale L. Phelps, MD
University of Rochester
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
SP16 Inflammatory Response Inhibition Trial
SP16 SERPIN-like Peptide Administration in Healthy Individuals
Treatment of Acute Pericarditis With Anakinra
Alirocumab in Patients With Acute Myocardial Infarction
Treatment of Diabetes in Patients With Systolic Heart Failure
Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)
Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction
Interleukin-1 Blockade in Recently Decompensated Heart Failure
Interleukin-1 Blockade in HF With Preserved EF
All 12 trials loaded